Zentalis Pharmaceuticals, Inc.·4

Feb 5, 6:29 PM ET

EASTLAND JULIA MARIE 4

4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 5, 2025

Insider Transaction Report

Form 4
Period: 2025-02-03
EASTLAND JULIA MARIE
DirectorCEO & President
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-03+59,38859,388 total
    Exercise: $1.68Exp: 2035-02-02Common Stock (59,388 underlying)
  • Award

    Common Stock

    2025-02-03+59,38887,888 total
Footnotes (2)
  • [F1]Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer.
  • [F2]The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Documents

1 file
  • 4
    wk-form4_1738798191.xmlPrimary

    FORM 4